Personalis, Inc. (PSNL) vs GeneDx Holdings Corp. (WGS)

Personalis, Inc. and GeneDx Holdings Corp. are both Diagnostics & Research companies. GeneDx Holdings Corp. is the larger, with a market value of $2.6B against $1.8B — 1.5× the size. GeneDx Holdings Corp. grew revenue faster over the last twelve months: 25.4% against −13.3%. GeneDx Holdings Corp. has the higher net margin (−23.4% vs −153.8%) and the higher return on invested capital (−27.7% vs −317.5%). Across the 18 metrics below, GeneDx Holdings Corp. leads on 15 and Personalis, Inc. on 3.

Valuation

Metric PSNL WGS Diagnostics & Research median
P/E n/m n/m 33.95
P/S 24.91 5.78 4.87
P/B 7.38 10.75 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 22.42 5.70 5.66
Earnings yield (6.62%) (4.12%) (1.75%)
Free cash flow yield (5.81%) (2.89%) (0.13%)

Profitability

Metric PSNL WGS Diagnostics & Research median
Gross margin 12.69% 69.37% 50.89%
Operating margin (164.07%) (20.34%) (8.57%)
Net margin (153.84%) (23.40%) (6.37%)
Free cash flow margin (144.76%) (16.68%) 0.00%
Return on equity (50.32%) (40.80%) (2.92%)
Return on assets (37.55%) (22.50%) (6.71%)
Return on invested capital (317.48%) (27.70%) 0.00%

Growth

Metric PSNL WGS Diagnostics & Research median
Revenue growth (TTM) (13.26%) 25.42% 7.69%
EPS growth (last fiscal year) 33.58% 62.37% —
Revenue growth, 5-year CAGR (2.40%) 18.98% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PSNL WGS Diagnostics & Research median
Debt to equity 0.00 0.40 0.11
Current ratio 5.28 3.30 2.02
Net debt to EBITDA 2.93 (10.13) 0.78

Dividend

Metric PSNL WGS Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric PSNL WGS Diagnostics & Research median
Market cap 1.77b 2.61b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack